| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27155ed29f9b0bfa281f4b21b26d709a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-27 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
2000-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2005-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fd7a2d00f1b3de359b8023bf9bbb01f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_187cc40268ed137ceb9689b8c7c23c7f |
| publicationDate |
2005-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6869600-B1 |
| titleOfInvention |
Combined treatment of multiple sclerosis |
| abstract |
The use of growth hormone (GH) together with an interferon (IFN) to produce a pharmaceutical composition for treating multiple sclerosis and/or other demyelinating diseases is disclosed. Disclosed are also pharmaceutical compositions for treating multiple sclerosis and/or other demyelinating diseases. Disclosed are also pharmaceutical compositions for the simultaneous, separate or sequential use of its active ingredients for the above specified therapy. In particular, the advantage of EP0003504 of GH together with IFN-β to produce a pharmaceutical composition for the treatment of multiple sclerosis are shown. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020197334-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8691790-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105050621-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105050621-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009012569-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014127258-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9758573-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011020311-A1 |
| priorityDate |
1999-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |